Clinical Trial Update: DESyne X2 Post Market Follow-up Study [NA]

View source ↗

Summary

Post-market follow-up study update for the DESyne X2 device; the trial was terminated and results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• DESyne X2 (DESyne X2)

Snippet

Sponsor: Elixir Medical Corporation | Conditions: Coronary Artery Disease | NA | Status: TERMINATED | Results posted: 2023-10-25